SCHEMBL407972

SCHEMBL407972

O=C1CC(=S)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176102 0.77
SCHEMBL8660061 0.73
SCHEMBL1509853 0.71
Thiobarbituric SCHEMBL16027 0.71
SCHEMBL41851 0.71
Water SCHEMBL7264692 0.69 TDP2 (0.39)
Thiobarbituric SCHEMBL2351184 0.69 GSK3A (0.36)
Thiobarbituric SCHEMBL8216351 0.69 GSK3A (0.36)
Thiobarbituric SCHEMBL2344775 0.69 GSK3A (0.36)
Hydrochloric Acid SCHEMBL10924919 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3264 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946460-B1 IMPROVED CONJUGATION LINKERS PROLYNX LLC (US) 2026-05-20 EP claimed
EP-4727583-A1 T CELL ENGAGER MASKING MOLECULES AMGEN INC. (US) 2026-04-22 EP claimed
EP-4704904-A1 TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD Tambo, Inc. (US) 2026-03-11 EP claimed
EP-4682154-A1 PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF OLIGOSACCHARIDES REPRESENTING SEGMENTS OF O-ANTIGENS FROM DIVERSE SHIGELLA FLEXNERI SEROTYPES Institut Pasteur (FR) 2026-01-21 EP claimed
US-20250387503-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S (DK) 2025-12-25 US claimed
EP-4646231-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS Ascendis Pharma Ophthalmology Division A/S (DK) 2025-11-12 EP claimed
EP-4199970-B1 EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS RIGSHOSPITALET (DK) 2025-10-15 EP claimed
EP-4615476-A2 PREPARATION OF LIPID NANOPARTICLE (LNP) CONJUGATES Tessera Therapeutics, Inc. (US) 2025-09-17 EP claimed
EP-4598980-A2 COMPOSITIONS FOR MICROFLUDIC WORKFLOWS AND METHODS OF USE THEREOF Bruker Cellular Analysis, Inc. (US) 2025-08-13 EP claimed
US-20250250397-A1 ANISOTROPIC POLY(ETHYLENE GLYCOL)-BASED HYDROGELS SYNTHESIZED VIA TWO-STAGE POLYMERIZATION AND MECHANICAL ALIGNMENT UNIVERSITY OF OREGON (US) 2025-08-07 US claimed
CN-101231293-A Method for detecting vestigial clenbuterol INST OF HYGIENE AND ENVIRONMEN (CN) 2008-07-30 CN claimed
CN-1974583-A Prepn process of diphosphonate derivative UNIV NORTHWEST POLYTECH (CN) 2007-06-06 CN claimed
CN-1935790-A Method for synthesizing N-hydroxy thiosuccinimide salt ENZI PHARMACEUTICAL NANJING CO (CN) 2007-03-28 CN claimed
CN-1268346-C Biological polysaccharide micro-capsule, prepn. method and application thereof ZHONGKE WUBAIHAO BIOLOG ENGINE (CN) 2006-08-09 CN claimed
CN-1618434-A Biological polysaccharide micro-capsule, prepn. method and application thereof ZHONGKE WUBAIHAO BIOLOG ENGINE (CN) 2005-05-25 CN claimed
CN-1458525-A Integrated capillary biological chip and its producing method GUO ZHANJUN (CN) 2003-11-26 CN claimed
CN-1438244-A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof GUO ZHANJUN (CN) 2003-08-27 CN claimed
US-4874874-A REACTING SULFENYLSUCCINIMIDE WITH HYDROGEN PEROXIDE IN ACID SOLVENT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-17 US claimed
EP-0269837-A2 Process for the preparation of 3-sulfenylmaleimides and their use BAYER AG (DE) 1988-06-08 EP claimed
US-4001025-A SILVER SULFIDE, DIGESTION MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1977-01-04 US claimed